Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2024-01-25 Director's Dealing
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider shareholdings and changes in ownership by directors or major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions and ownership reports by company directors and executives.
2024-01-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the change in share ownership by a major shareholder (ACS DOBFAR S.P.A) and related parties in the company 'Hi-Tech Pharm'. Since this is a specific regulatory disclosure regarding share ownership thresholds and changes, it falls under the 'Major Shareholding Notification' category.
2024-01-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose their shareholdings and changes therein. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership by company directors and executives.
2024-01-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership by directors or major shareholders. This falls under the 'Director's Dealing' category as it reports the personal share transactions and ownership status of a company executive (Choi Deok Keun).
2024-01-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by company insiders to disclose their shareholdings and changes therein. This corresponds to the 'Director's Dealing' category, which covers insider trades and ownership reports by company directors and executives.
2024-01-08 Korean
권배락(무상증자 및 배당)
Notice of Dividend Amount Classification · 100% confidence The document is a short notice regarding '권배락' (ex-rights/ex-dividend date) for Hitech Pharm, specifically detailing a bonus issue (무상증자) and dividend (배당). This type of corporate action announcement regarding capital changes and shareholder distributions fits the 'Share Issue/Capital Change' category.
2023-12-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.